|
|
Blood, 15 March 2004, Vol. 103, No. 6, pp. 2369-2376.
Prepublished online as a Blood First Edition Paper on November 13, 2003; DOI 10.1182/blood-2003-09-3050.
 Previous Article | Table of Contents | Next Article 
RED CELLS
Regulated secretion of glycosylated human ferritin from hepatocytes
Sharmistha Ghosh,
Sarah Hevi, and
Steven L. Chuck
From the Molecular Medicine Unit, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Serum ferritin has been used widely in clinical medicine chiefly as an indicator of iron stores and inflammation. Circulating ferritin also can have paracrine effects. Despite the clinical significance of serum ferritin, its secretion remains an enigma. The consensus view is that serum ferritin arises from tissue ferritins— principally ferritin light—which can be glycosylated. Ferritin heavy and light chains are cytosolic proteins that form cages of 24 subunits to store intracellular iron. We show that ferritin light is secreted when its expression is increased in stable, transfected HepG2 cells or adenovirus-infected HepG2 cells. Export occurs through the classical secretory pathway and some chains are N-glycosylated. Ferritins do not need to form cages prior to secretion. Secretion is blocked specifically, effectively, and rapidly by a factor in serum. The timing of this inhibition of ferritin secretion suggests that normally cytosolic ferritin L is targeted to the secretory pathway during translation despite the absence of a conventional signal sequence. Thus, secretion of glycosylated and unglycosylated ferritin is a regulated and not a stochastic process.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Kannengiesser, A.-M. Jouanolle, G. Hetet, A. Mosser, F. Muzeau, D. Henry, E. Bardou-Jacquet, M. Mornet, P. Brissot, Y. Deugnier, et al.
A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload
Haematologica,
March 1, 2009;
94(3):
335 - 339.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Ferring-Appel, M. W. Hentze, and B. Galy
Cell-autonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism
Blood,
January 15, 2009;
113(3):
679 - 687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Missirlis, S. Kosmidis, T. Brody, M. Mavrakis, S. Holmberg, W. F. Odenwald, E. M. C. Skoulakis, and T. A. Rouault
Homeostatic Mechanisms for Iron Storage Revealed by Genetic Manipulations and Live Imaging of Drosophila Ferritin
Genetics,
September 1, 2007;
177(1):
89 - 100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Wilker, J. R. Sedy, V. Grigura, T. L. Murphy, and K. M. Murphy
Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family
Int. Immunol.,
June 1, 2007;
19(6):
763 - 773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J M van de Kamp, D J Lefeber, G J G Ruijter, S J Steggerda, N S den Hollander, S M Willems, G Matthijs, B J H M Poorthuis, and R A Wevers
Congenital disorder of glycosylation type Ia presenting with hydrops fetalis
J. Med. Genet.,
April 1, 2007;
44(4):
277 - 280.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-H. Yang, J. Szeliga, J. Jordan, S. Faske, Z. Sever-Chroneos, B. Dorsett, R. E. Christian, R. E. Settlage, J. Shabanowitz, D. F. Hunt, et al.
Identification of the Surfactant Protein A Receptor 210 as the Unconventional Myosin 18A
J. Biol. Chem.,
October 14, 2005;
280(41):
34447 - 34457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Maciel, V. T. Cruz, M. Constante, I. Iniesta, M. C. Costa, S. Gallati, N. Sousa, J. Sequeiros, P. Coutinho, and M. M. Santos
Neuroferritinopathy: Missense mutation in FTL causing early-onset bilateral pallidal involvement
Neurology,
August 23, 2005;
65(4):
603 - 605.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
